October 30, 2025

New Coronavirus Found in Brazilian Bats: What Toxicology and Product Development Must Learn Now

When Discovery Meets Responsibility Scientists in Brazil have discovered a previously unknown coronavirus in bats — one that carries genetic similarities to MERS-CoV, the virus responsible for deadly outbreaks in the Middle East. (University of Nebraska Medical Center, 2025 ) For professionals in biotech, toxicology, and product development, the message is urgent and clear:
October 29, 2025

Lynkuet (Elinzanetant): What Toxicology and Product Development Teach Us About Safe Innovation

Mechanism Meets Safety Lynkuet (elinzanetant) is one of the first non-hormonal medicines approved to treat moderate to severe hot flashes and night sweats caused by menopause (EMA, 2025). It’s a major step forward — and a powerful reminder for developers of one core truth:
October 28, 2025

Can LED Light Really Kill Cancer? What Toxicology Teaches Us About Safety, Innovation, and Smart Design

Light as Medicine — and a Safety Challenge You may have seen the headline:  “LED light can kill cancer cells.” It sounds futuristic — shining light on a tumor instead of blasting it with radiation or flooding it with chemotherapy. But this idea isn’t fantasy. It’s called photodynamic therapy (PDT) — and it’s a real area of cancer research that’s gaining traction
October 27, 2025

FDA Recalls Cholesterol Medication — What Toxicology Can Teach Developers About Hidden Risks

When “Safe” Products Become a Safety Lesson The U.S. Food and Drug Administration (FDA) recently announced a recall of several cholesterol-lowering medications after routine testing detected nitrosamine impurities — chemicals that can increase cancer risk following long-term exposure. For patients, the immediate health risk is low. For scientists, regulators, and developers, however, this is a powerful reminder:
gdpr-image
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.and Cookie policy
Read more
💬

Chat with us